Please login to the form below

innovation in life sciences

This page shows the latest innovation in life sciences news and features for those working in and with pharma, biotech and healthcare.

Plasticell and London’s gene therapy pioneers to tackle manufacturing conundrum

The scientific consortium, led by Plasticell, will fund this project partly through a competitive, non-dilutive grant of £740, 000, obtained from Innovate UK as part of its ‘Innovation in Health ... and Life Sciences’competition.

Latest news

Prix Galien opens for entries with new award

The process culminates in a ceremony at the House of Commons on 26 September 2018. ... Judges will be looking for innovations that demonstrate the most significant overall contribution to patient care in the UK in terms of clinical effectiveness, cost
Chiesi's Holoclar wins UK Prix Galien orphan drug award

The Judging Panel agreed that it was tremendous to see this level of innovation in an orphan indication.”. ... depth and diversity of medical innovation in UK life sciences. “
Cancer Drugs Fund axes 16 treatments after overspending

where life sciences investment and innovation in the UK is being put in genuine jeopardy.”. ... Dr Daniel Thurley, medical director of Roche, said: “ A stop and start approach to providing access to highly-innovative, life-changing cancer medicines
NHS 'not driving' health innovation

Minister for Life Sciences George Freeman admitted that more must to be done to improve the uptake of innovation in the NHS. ... He joined pharma leaders on a panel last week discussing how regional initiatives can forge new R&D investment, collaboration
Nothing makes sense

nothing in the life sciences industry makes sense except in the light of evolution. ... One selection pressure in the life sciences environment favours innovation in technically difficult areas; another selection pressures favour low cost, low innovation

More from news
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest Intelligence

The challenges of making genomics a reality for patients

The appraisal system in the UK needs to reflect that specific genes and pathways underlying genetic diseases seldom respond to traditional pharmaceutical approaches and so precision medicine requires risk-taking innovation. ... The Life Sciences
The challenges of making genomics a reality for patients today, not tomorrow

The appraisal system in the UK needs to reflect that specific genes and pathways underlying genetic diseases seldom respond to traditional pharmaceutical approaches and so precision medicine requires risk-taking innovation. ... The Life Sciences

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

CBI, UBM Life Sciences

CBI, UBM Life Sciences. Powering thought leadership through leaderships, partnerships and innovation in life sciences. ... CBI, UBM Life Sciences.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.